A breakthrough vaccine for breast and gastric cancer is in trials

A VACCINE that treats one of the most common forms of breast cancer is being developed by an Aussie company and one day it could be used to prevent cancer.

The therapy stimulates the body’s own immune system to fight the cancer and studies have showed it produced improved survival rates in mice.

The vaccine will help the one in four women whose breast cancer over expresses the HER2 protein as well as HER2 gastric cancer patients.

Over 1 million cases of gastric cancer are diagnosed each year, mostly in Asia, and the five year survival rate is just 30 per cent.

Trials in Europe have already shown the vaccine is safe and it is now being trialled in Asia on gastric cancer patients. Read more… 

Join Our Mailing List